Lanxess has improved its EBITDA margins significantly through self-help measures, and there is potential for further improvement as volumes recover. The company's restructuring and cost efficiencies are expected to continue benefiting its financial performance, and its fair value is estimated to be 15%-25% higher than current prices, indicating a positive short-term impact on the stock price.